• No results found

DAILY REVIEW 19 DECEMBER 2017

N/A
N/A
Protected

Academic year: 2021

Share "DAILY REVIEW 19 DECEMBER 2017"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

(1)

Rowsley Ltd ($0.136, up 0.025) entered into a binding Acquisi on Agreement with Mr. Peter Lim Eng Hock to acquire 100% of Sasteria Pte Ltd (“Sasteria”), the owner of Thomson Medical Pte Ltd (“Thomson Medical”) and the controlling shareholder of TMC Life Sciences Berhad (“TMCLS”). Under the agreement, Rowsley will acquire a 100% stake in Thomson Medical, Singapore’s largest private provider of healthcare services for women and children and a 70.36% stake in TMCLS, a Bursa Malaysia-listed healthcare company with a mul -disciplinary ter ary hospital and leading provider of in-vitro fer lisa on (“IVF”) services in Malaysia. Rowsley also intends to change its name to Thomson Medical Group Limited.

The Purchase Considera on of S$1.6 billion for Sasteria will be sa sfi ed through 21.3 billion new Rowsley shares at the issue price of S$0.075 per share. Rowsley will also acquire 597,319,140 TMCLS Warrants in cash, each at a price equal to the volume-weighted average price of TMCLS Warrants traded on Bursa Malaysia, for the one-month period immediately preceding the date falling four market days prior to the date of the Extraordinary General Mee ng (“EGM”) to be convened. The total considera on was arrived at on a willing-buyer willing-seller basis and taking into account amongst others the profi tability of Thomson Medical, TMCLS, their growth poten al and synergies with Rowsley’s Vantage Bay Healthcare City development. Both Thomson Medical and TMCLS have plans to capitalise on the increasing demand for healthcare services in the region. Thomson Medical will con nue to grow beyond its current core obstetrics and gynaecology services into an integrated country-wide healthcare network by expanding its current service off erings and opening more new specialist clinics.

In Malaysia, TMCLS has plans to make its ter ary hospital (“Tropicana Medical Centre”) at Kota Damansara one of the largest integrated healthcare campuses in the Klang Valley by tripling its current bed capacity. When the new expansion wing is completed and fully opera onal, the hospital will have a capacity of up to 600 beds, off ering comprehensive ter ary healthcare services. In addi on, TMCLS has plans to expand in Johor Bahru through the proposed Thomson Iskandar Medical Hub. Located in Vantage Bay Healthcare City in Johor Bahru just fi ve minutes’ drive from the Causeway, Thomson Iskandar Medical Hub will be an integrated development that comprises a 500-bed ter ary hospital, a 400-suite medical tower, and a complementary retail space. The ter ary hospital, Hospital Iskandariah, will be equipped with state-of-the-art facili es and equipment, and will have seven Centres of Excellence in cardiology, diabetes, fer lity, gastroenterology, oncology, orthopaedics and urology.

Exis ng Rowsley shareholders will be off ered two (2) Bonus Warrants for each exis ng share. Each Bonus Warrant has an exercise price of S$0.09. For every Bonus Warrant exercised, an addi onal warrant (“Piggyback Warrant”) can be exercised on the basis of one (1) Piggyback Warrant for every one (1) Bonus Warrant. Each Piggyback Warrant has an exercise price of S$0.12 per share. The Bonus Warrants and Piggyback Warrants are exercisable from the date of issue of the Bonus Warrants, up to the market day immediately preceding the fi rst and fourth anniversary of the issuance of the Bonus Warrants respec vely. If all the Bonus Warrants and Piggyback Warrants are exercised, Rowsley will receive approximately S$850 million and S$1,130 million of proceeds respec vely, which will be used to fund its future growth and working capital.

Among other condi ons, the transac on is subject to regulatory approvals, minority shareholder approvals, and the successful fulfi lment of the other condi ons set out in the Acquisi on Agreement. The EGM is expected to be held in the fi rst quarter of 2018. A shareholder’s circular containing further details of the transac on and enclosing the no ce of EGM will be dispatched to shareholders in due course. Rowsley has appointed Credit Suisse (Singapore) Limited as its fi nancial adviser in rela on to the Proposed Transac ons.

While promising, we note that the total acquisi on price of S$1.64bln against profi ts of S$32.8mln (Aug’17) suggests an acquisi on PE of 50x. This is not cheap compared to Raffl es Medical’s 27x and HMI’s 28x. The 50x PE is only cheaper than IHH healthcare’s 60x, but IHH healthcare is a global healthcare operator versus Thomson Medical Group’s Singapore and Malaysia exposure.

2750 2850 2950 3050 3150 3250 3350 3450 3550 12/16 01/17 02/17 03/17 04/17 05/17 06/17 07/17 08/17 09/17 10/17 11/17

52-week price chart

FINANCIAL MARKETS

FSSTI INDEX

Source: Bloomberg CLOSE (%)1D MTD(%) YTD(%) FSSTI 3414.8 -0.1 -0.5 18.5 Dow Jones 24792.2 0.6 2.1 25.5 S&P 500 2690.2 0.5 1.6 20.2 NASDAQ 6994.8 0.8 1.8 29.9 FTSE (UK) 7537.0 0.6 2.9 5.5 Nikkei 22901.8 1.5 0.8 19.8 Hang Seng 29050.4 0.7 -0.4 32.0 Shanghai Composite 3267.9 0.1 -1.5 5.3 VIX 9.5 1.2 -15.5 -32.1

Daily Market Value (S$'m) 1011.2 Daily Market Volume (mln) 1523.4 52-week STI High 3469.4 52-week STI Low 2857.9

CLOSE (%)1D MTD(%) YTD(%)

3 Mth SGD SIBOR 1.2 0.0 1.1 25.1 3 Mth Swap Offer Rate 1.1 1.4 -1.8 8.7 SG 10 YR Bond Yield 2.0 1.7 -7.2 -20.0 US 10 YR Bond Yield 2.4 1.8 -0.6 -2.0

As at 8.00am SG time CLOSE (%)1D MTD(%) YTD(%)

Dow Jones 24646.0 0.4 1.5 26.0 S&P 500 2694.4 0.5 1.7 21.0 NASDAQ 6537.3 0.0 2.4 34.1 CLOSE (%)1D MTD(%) YTD(%) Gold 1261.5 -0.1 -1.1 9.5 Crude Oil 57.2 -0.2 -0.4 6.4 Baltic Dry 1619.0 -2.9 2.6 68.5 Crude Palm Oil 2528.0 -0.9 -4.0 0.0

COMMODITIES

US FUTURES

KEY INTEREST RATES

SG MARKET SUMMARY

MAJOR MARKET INDICES

IDEA OF THE DAY

US stocks surged 0.6-0.8% into record territory on the back of expecta ons that “Trump’s” tax bill will be passed soon.

LIM & TAN SECURITIES 16 COLLYER QUAY #15-00 INCOME @ RAFFLES SINGAPORE 049318 TEL: 65330595 www.limtan.com.sg

RCB REG NO. 197301030W

(2)

OTHER HIGHLIGHTS

FSSTI STOCK SELECTION

1 HUTCHISON PORT-U 6.46

2 ASCENDAS REIT 5.93

3 SINGAPORE TELECOMS 5.74

4 STARHUB 5.61 5 COMFORTDELGRO 5.50

HIGHEST CONSENSUS FY17E DIV YIELD (%)

LOWEST CONSENSUS FY17 P/E (X)

1 HONGKONG LAND 0.50 2 HUTCHISON PORT-U 0.69 3 UOL GROUP 0.79 4 JARDINE STRATETIC 0.81 5 CAPITALAND 0.82 LOWEST TRAILING P/B (X)

LOWEST TRAILING EV/EBITDA (X) Ci c Envirotech ($0.735, up 0.5 cents) announced that it has been

awarded a RMB130mln (S$27mln) Engineering, Procurement and Construc on project in Xiangban City, Fujian Province, China. The project is awarded by Fujian Haixia Environmental Protec on Group Co. Ltd and involves the upgrading and expansion of Fujian Haixia’s exis ng 80,000 m3/day conven onal wastewater treatment plant into a 90,000 m3/day plant using the Group’s Membrane Bioreactor technology. The project will commence immediately and is expected to be completed by 30-Jun-18. The project has no material eff ect on the NTA per share or EPS of the Company for FY17.

Pacifi c Radiance ($0.102, down 1.7 cents) updated that the fi rst Informal Mee ng with the Noteholders to update the Noteholders on the Restructuring has been completed. This is with reference to the Series 001 4.30% Notes due 2018 issued under its S$1bln Mul currency Debt Issuance Programme. As discussions with other stakeholder groups are s ll ongoing, the Company will make further announcements of any signifi cant development in connec on to the Restructuring at the appropriate juncture.

ASTI Hldgs ($0.088, unchanged) announced that it has entered into a term sheet with Shanghai Pudong Science and Technology Investment Co., Ltd. (“PDSTI”), in rela on to PDSTI’s poten al acquisi on of the en re issued and paid-up share capital of several wholly-owned subsidiaries of ASTI (collec vely known as STI Group). STI Group designs, builds and markets semiconductor manufacturing equipment used in the produc on of Integrated Circuits, which are widely used in industries such as automo ve, communica ons, consumer electronics, data processing and aerospace. With a broad spectrum of quality products, STI Group has been profi table over the past few years.

PDSTI, established in 1999 in Shanghai, the People’s Republic of China, is an investment company currently focused on domes c and cross-border investments in integrated circuit, health care and other high-tech industries, with a current registered capital of RMB3bln. Its shareholders include Shanghai HTY Venture Investment Partnership (Limited Partnership), Shanghai Shangshi Asset Management Co., Ltd., and Shanghai Pudong Investment Holding Co., Ltd. ASTI and PDSTI will have exclusive nego a on for 60 days from the eff ec ve date of the term sheet.

The indica ve considera on for the transac on is S$100mln, subject to net debt and net working capital adjustments. In comparison, ASTI has a current market capitaliza on of approximately S$60mln as at 18-Dec-17.

OUE Lippo Healthcare ($0.123, down 0.2 cents) refers to the alleged claims made by Ms Lim Beng Choo that were informed to the Company on or around 26-Jan-17 and 07-Apr-17, and now wishes to update shareholders that the Company has yesterday been served with court documents by Ms Lim’s lawyers following Ms Lim’s commencement on 13-Dec-17 of court proceedings against the Company for the sum of S$60k, being the alleged amount due and owing to her for unpaid salaries. The Company is consul ng its legal advisors and will instruct them on the appropriate ac on to take on behalf of the Company.

Sen Yue ($0.032, up 0.1 cent) announced that it has been informed by Mr Kevin Norbert Scully, the Lead Independent Director, Audit Commi ee Chairman, and member of the Nomina ng and Remunera on Commi ees of the Company, that the Monetary Authority of Singapore has issued a prohibi on order against Mr Kevin Norbert Scully. Informa on leading to the Prohibi on Order can be found in the announcement released by MAS dated 30-May-17. Pursuant to the Prohibi on Order, Mr Kevin Norbert Scully is prohibited from providing any fi nancial advisory service for a period of three years commencing on 18-Dec-17, among other issues. Jumbo Group ($0.575, down 1.5 cents) announced that its

wholly-owned subsidiary, Jumbo Group of Restaurants Pte. Ltd. (the “Franchisor”), has entered into a franchise agreement with Ho Sing Food Co., Ltd, pursuant to which Ho Sing shall establish and operate JUMBO Seafood restaurants in Taiwan. Following the entry into this franchise agreement, the Group is also pleased to announce that the 1st JUMBO Seafood outlet in Taiwan opened on 16-Dec-17. This franchise agreement has an ini al term of 10 years and may

be renewed for a further 10 years subject to certain condi ons to be determined by the Franchisor. The Franchise Agreement also envisages that eight JUMBO Seafood outlets will be opened in Taiwan.

MindChamps ($0.77, up 1.5 cents) announced that Evergrande Group in Vietnam has signed a Master Franchise Agreement with MindChamps PreSchool Limited, with plans to open 20 PreSchool and Reading centres in Vietnam. MindChamps brings to Vietnam it’s unique 3-Minds approach to educa on, based on the trinity of the Learning Mind, the Crea ve Mind and the Champion Mind, according to management.

(3)

SHARE TRANSACTIONS

13 - 15 DECEMBER

SEPTEMBER

Company

Party

Buy

Sell

Transacted

Price* ($)

Market

Price ($)

New

Balance

Stake

(%)

ACQUISITIONS

Avi-Tech Electronics Lim Eng Hong 101,500 - 0.459 - 59,874,975 35.01

BHG Retail Reit Beijing Hualian Group Invt Hldg 1,000,000 - 0.74 - 170,558,786 34.13

DBS Group Holdings Nihal Vijaya Devadas Kaviratne 6,750 - 25.20 - 31,300 0.00

Maxi-Cash Financial Servies Koh Wee Seng 500,000 - 0.163 - 738,697,087 81.12

UOB-Kay Hian Holdings Wee Ee Chao 1,400 - 1.36 - 209,681,674 26.45

DISPOSALS

AGV Group Catherine Chan - 187,000 0.15 - 15,140,500 12.01

* ND: Not Disclosed

SHARE BUYBACK

Company

No. of shares

Price

($)

CumulaƟ ve

Purchases

Of Maximum

(%)

Mun Siong Engineering 500,000 0.07 1,638,000 2.9

(4)

Company

ConsolidaƟ on RaƟ o

Ex-Date

Record Date

Changjiang Fer liser Consolida on 40 into 1 19 Dec 2017 21 Dec 2017

SHC Capital Asia Consolida on 7 into 1 20 Dec 2017 22 Dec 2017

Company

Amount

Last Day

Cum-Dividend

Ex-Dividend

First Day

Payable

Date

SingTel 6.8¢ interim / 3¢ special 15 Dec 18 Dec 10 Jan

Top Glove Corpora on Ringgit8.5sens fi nal 09 Jan 2018 10 Jan 2018 25 Jan 2018

Frasers & Neave 3¢ fi nal 30 Jan 2018 31 Jan 2018 14 Feb 2018

Frasers Cetnrepoint 6.2¢ fi nal 30 Jan 2018 31 Jan 2018 14 Feb 2018

Thai Beverage Public Co THB0.47 fi nal 07 Feb 2018 08 Feb 2018 28 Feb 2018

DIVIDENDS (LIST IS NOT EXHAUSTIVE)

(5)

D›‘›Ã›Ù 2017

Sun Mon Tue Wed Thu Fri Sat

1 US November ISM

Manufacturing

2

3 4 US October Factory Orders

5 Del Monte Pacifi c

6 EMAS Off shore

7 8 US November Change In

Nonfarm Payrolls

9

10 11 China November CPI

12 Singapore October Retail Sales

13 14 US December FOMC Rate

Decision

15 16

17 18 Singapore November Non-Oil

Domes c Exports China November Property

Prices

19 20 21 US 3Q GDP

22 23

24 25 26 Singapore November CPI

27 Second Chance Proper es

28 29 30

31

(6)

47 Companies

Minimum Trading Price Only

23 Companies

Minimum Trading Price &

Profi tability And Market Cap

15 Companies

Profi tability And Market

Cap Only

32 Companies

Granted Extension To Be Assessed For

Minimum Trading Price In September

8Telecom A-Sonic Aerospace Advance SCT Asia Enterprises

Ace Achieve A lan China Essence Ban Leong Technologies*

Asia Fashion BH Global China Hongcheng BBR

ASTI Blumont CNA Group Broadway

AusGroup Cacola Furniture Global Yellow Pages C&G Environmental

Beng Kuang Chinasing HL Global China Sky

Casa Holdings China Taisan Lafe Corp Dyna-Mac

Chasen Compact Metal Industries Lankom Electronics Ezra

China Dairy Dapai Interna onal Miyoshi Precision Falcon Energy*

China Gaoxian Fibre Fabric Dragon Group Next-Gen Satellite Fragrance

China Great Land Europtronic Novo Group Global Invacom

China Haida FJ Benjamin Pacifi c Healthcare Hafary

China Sports Full Apex PSL Holdings Innotek

Chiwayland Huan Hsin S i2i King Wan*

Cosmosteel Informa cs Texchem-Pack KrisEnergy*

Fabchem China Innopac Manha an Resources

Foreland Fabrictech Interra Resources Marco Polo Marine

Forise Interna onal Mirach Energy Mermaid Mari me

Global Yellow Pages MMP Resources Nam Cheong

Hoe Leong Nippecra OKH Global*

Hu An Cable Ossia Interna onal Parkson Retail Asia*

Ipco Interna onal Oceanus Ramba Energy*

ISR Capital Swee Hong RH Petrogas

Jackspeed Rickmers Mari me

Jadason Soup Restaurant

KS Energy Sunvic Chemical*

KTL Global Swissco Holdings*

Leader Environmental Tee Land

Lorenzo UPP

Luzhou Bio-Chem Vard Holdings*

M Development Ying Li

Mun Siong Yuuzoo

Nico Steel

Nutryfarm Interna onal Ouhua Energy

Pavillon * Issuers which have been granted

Plastoform Holdings an extension of me on 01 June 2016

Qian Hu

Regal Interna onal Seroja Investments Star Pharmaceu cal Suntar Eco-City The Stratech Group Travelite Holdings USP Holdings Vibropower Corp Ziwo

(7)

RESEARCH DISCLAIMER

This report is intended for clients of Lim & Tan Securities Pte Ltd [herein after termed as LTS] only and no part of

this document may be –

i. Copied, photocopied, duplicated, stored or reproduced in any form by any means or

ii. Re-distributed or disseminated, directly or indirectly, to any other person in whole or in part, for any purpose

without the prior consent of LTS.

This research report is prepared for general circulation. It does not have regard to the specifi c investment objectives,

fi nancial situation and particular needs of any specifi c recipient of this research report. You should independently

evaluate particular investments and consult your independent fi nancial adviser before making any investments or

entering into any transaction in relation to any securities or investment instruments mentioned in this report.

The information, tools and material presented herein this report are not directed at, or intended for distribution to

or use by, any person or entity who is a citizen or resident of or located in any jurisdiction where such distribution,

publication, availability or use would be contrary to applicable law or regulation or which would subject LTS to any

registration or licensing requirement within such jurisdiction.

The information and opinions presented in this research report have been obtained or derived from sources believed

by LTS to be reliable. Their accuracy, completeness or correctness is, however, not guaranteed. Opinions and

views expressed in this report are subject to change without notice, and no part of this publication is to be construed

as an offer, or solicitation of an offer to buy or sell securities, futures, options or other fi nancial instruments or

to provide investment advice or services. Therefore, LTS accepts no liability for loss arising from the use of the

material presented in this report where permitted by law and/or regulation. LTS may have issued other reports that

are inconsistent with the assumptions, views and analytical methods of the analysts who prepared them.

LTS, its directors, its connected persons and employees may, from time to time, own or have positions in any of the

securities mentioned or referred to in this report or any securities related thereto and may from time to time add to or

dispose of or may be materially interested in any such securities. LTS’s research analysts are primarily responsible

for the content of this report, in part or in whole, and certifi es that the views about the companies expressed in

this report accurately refl ect his personal views. LTS prohibits the research analysts who prepares this report

from receiving any compensation (excluding salary and bonuses) or other incentives and benefi ts receivable in

respect of this report or for providing specifi c recommendation for, or in view of a particular company or companies

mentioned in this report.

LTS-SPECIFIC / REGULATORY DISCLOSURE

1. LTS does have a proprietary position in Rowsley Ltd as recommended in this report as at the close of 18/12/17.

2. The research analysts do not hold *interests in the company / companies as recommended in this report as at

the close of 18/12/17

* Includes direct or indirect ownership of securities or Futures Contracts (excluding the amount of securities or Futures Contracts owned), directorships or trustee positions.

References

Related documents

The aim of this study was to determine whether or not the type of medicines (medicine for lifestyle or disease treatment) related to the socioeconomic factors based on the

– There  is  no  “silver  bullet”  - we will need a range of technologies to meet targets – A better understanding of life cycle emissions will enable more informed choices

We then tested whether these measures have a significant influence on individual investment behavior under different formats of uncertainty that included pure risk and two levels

Second, research on the topic has focused on the non-transactional consequences of engagement (e.g. Consequently, it is necessary to gain a better understanding about the

In general transcription from pBC210 ORFs increases during stationary phase growth and several genes encoding capsule biosynthesis proteins are more highly expressed

Nowadays we now have major and minor keys for different flavours of tune, go back far enough and they had modes, 7 of them, one starting on each of the 7 notes and they gave

The workshop consists of standing and sitting yoga exercises which gives strength, body energy and wellbeing.. Choreography and composition at a level where everyone with lots

Here, we present the first search for prompt radio emission accompanying a gravitational-wave event, targeting the binary black hole merger GW170104 detected by the Advanced